Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction

Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction

Myocardial infarction (MI) is a common cardiovascular disease caused by permanent loss of cardiomyocytes and the formation of scar tissue due to myocardial ischemia. Mammalian cardiomyocytes lose their ability to proliferate almost completely in adulthood and are unable to repair the damage caused b...

Full description

Bibliographic Details
Main Authors:	Yang Xiao, Yihuan Chen, Chunlai Shao, Yaning Wang, Shijun Hu, Wei Lei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	pluripotent stem cell cardiomyocyte myocardial infarction cell therapy cardiology
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2022.973496/full

Similar Items

Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes
by: Xin Jiang, et al.
Published: (2020-07-01)

Co-transplantation of Mesenchymal Stromal Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improves Cardiac Function After Myocardial Damage
by: Klaus Neef, et al.
Published: (2022-01-01)

Transplantation of induced pluripotent stem cells-derived cardiomyocytes combined with modified Taohong Siwu decoction improved heart repair after myocardial infarction
by: Zhi-rong Luo, et al.
Published: (2024-02-01)

Myocardial infarction and stem cells
by: K Ananda Krishna, et al.
Published: (2011-01-01)

In Situ Maturated Early-Stage Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improve Cardiac Function by Enhancing Segmental Contraction in Infarcted Rats
by: Diogo Biagi, et al.
Published: (2021-05-01)

Induced pluripotent stem cells differentiation into cardiomyocytes by rotating suspension culture and in specific plates with microwells
by: G. Budash, et al.
Published: (2016-11-01)

Modelling Metabolic Shifts during Cardiomyocyte Differentiation, Iron Deficiency and Transferrin Rescue Using Human Pluripotent Stem Cells
by: Benjamin B. Johnson, et al.
Published: (2021-12-01)

Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes
by: Yuichi Horikoshi, et al.
Published: (2019-09-01)

Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
by: Sho Tanosaki, et al.
Published: (2021-02-01)

Differentiation and characterization of rhesus monkey atrial and ventricular cardiomyocytes from induced pluripotent stem cells
by: Xiaoqian Zhang, et al.
Published: (2017-04-01)

Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure
by: Songyan Liao, et al.
Published: (2019-03-01)

Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts
by: Xumin Guan, et al.
Published: (2020-02-01)

Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence
by: Huifeng Zheng, et al.
Published: (2021-10-01)

Generation of Functional Cardiomyocytes from Human Gastric Fibroblast-Derived Induced Pluripotent Stem Cells
by: Chih-Hsien Wu, et al.
Published: (2021-10-01)

Therapeutic Use of Stem Cells for Myocardial Infarction
by: Mariah Madigan, et al.
Published: (2018-04-01)

In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy
by: Yun-Gwi Park, et al.
Published: (2022-06-01)

Epigenetic Regulation of Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells
by: Yong-Jin Kim, et al.
Published: (2021-08-01)

Analyzing Impetus of Regenerative Cellular Therapeutics in Myocardial Infarction
by: Ming-Long Chang, et al.
Published: (2020-04-01)

Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
by: Minh Nguyen Tuyet Le, et al.
Published: (2019-05-01)

Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes
by: Rou Chen, et al.
Published: (2019-03-01)

Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: Implications for disease modeling and maturation
by: Patrick Ernst, et al.
Published: (2023-01-01)

In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts
by: Shin Kadota, et al.
Published: (2017-02-01)

Xenogeneic-Free System for Biomanufacturing of Cardiomyocyte Progeny From Human Pluripotent Stem Cells
by: Preeti Ashok, et al.
Published: (2020-10-01)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
by: Maaike eHoekstra, et al.
Published: (2012-08-01)

Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch
by: Shigeru Miyagawa, et al.
Published: (2024-03-01)

Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes
by: Hao Yang, et al.
Published: (2023-08-01)

Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes
by: Christina Schmid, et al.
Published: (2021-11-01)

Epigenetic Modification Factors and microRNAs Network Associated with Differentiation of Embryonic Stem Cells and Induced Pluripotent Stem Cells toward Cardiomyocytes: A Review
by: Afshin Zare, et al.
Published: (2023-02-01)

Cardiomyogenesis Modeling Using Pluripotent Stem Cells: The Role of Microenvironmental Signaling
by: Amanda Leitolis, et al.
Published: (2019-08-01)

Toward the realization of cardiac regenerative medicine using pluripotent stem cells
by: Yoshikazu Kishino, et al.
Published: (2020-01-01)

Characterisation of sympathetic neurons and cardiomyocytes derived from human pluripotent stem cells and their therapeutic mechanism
by: Li, N
Published: (2024)

Differentiating Human Pluripotent Stem Cells to Cardiomyocytes Using Purified Extracellular Matrix Proteins
by: Ashlynn M. Barnes, et al.
Published: (2022-11-01)

APLNR marks a cardiac progenitor derived with human induced pluripotent stem cells
by: Yin-Yu Lam, et al.
Published: (2023-07-01)

Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes
by: Marzia De Bortoli, et al.
Published: (2023-01-01)

Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
by: Emma Claire James, et al.
Published: (2021-03-01)

Three-dimensional cardiac organoid formation accelerates the functional maturation of human induced pluripotent stem cell-derived cardiomyocytes
by: Hanbyeol Lee, et al.
Published: (2022-05-01)

MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction
by: Yueqiu Chen, et al.
Published: (2017-11-01)

Positive effect of Periostin on repair of Isopreternol induced ischemic damaged cardiomyocyte: an in vitro model
by: Saeideh Edalati, et al.
Published: (2022-06-01)

Excitation-contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes
by: Christopher eKane, et al.
Published: (2015-09-01)

Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy
by: Sophia E. Silver, et al.
Published: (2021-11-01)